R. Espadero

The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study.

H. Wollmann, M. Fernández-Cancio, A. Carrascosa, 2008, The Journal of clinical endocrinology and metabolism.

Longitudinal Study of the Pubertal Growth Spurt in Children Born Small for Gestational Age Without Postnatal Catch-up Growth

A. Carrascosa, E. Vicens-Calvet, R. Espadero, 2002, Journal of pediatric endocrinology & metabolism : JPEM.

The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.

H. Wollmann, M. Fernández-Cancio, M. Clemente, 2006, The Journal of clinical endocrinology and metabolism.

Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA.

H. Wollmann, M. Clemente, A. Carrascosa, 2006, The Journal of clinical endocrinology and metabolism.

Children born small for gestational age (SGA) who fail to achieve catch up growth by 2-8 years of age are short from infancy to adulthood. Data from a cross-sectional study of 486 Spanish children.

A. Carrascosa, D. Yeste, E. Vicens-Calvet, 2006, Pediatric endocrinology reviews : PER.